SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-182414
Filing Date
2018-06-04
Accepted
2018-06-04 06:10:34
Documents
4
Effectiveness Date
2018-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A d573627ddefa14a.htm DEFA14A 60893
2 GRAPHIC g573627g95o50.jpg GRAPHIC 25303
3 GRAPHIC g573627gg573627pc_page1.jpg GRAPHIC 136755
4 GRAPHIC g573627hh573627pc_page2.jpg GRAPHIC 85393
  Complete submission text file 0001193125-18-182414.txt   402970
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 18876783
SIC: 2834 Pharmaceutical Preparations